Hikma is an international pharmaceutical company conducting operations through three businesses: generic pharmaceuticals, branded pharmaceuticals and injectable pharmaceuticals. The company sells 113 branded and non-branded generic pharmaceutical products in 34 countries worldwide. The majority of Hikmas operations are in the United States, the Middle East and North Africa Region and Europe.
Registrars: |
CEO: | Riad Mishlawi |
Non-Executive Director: | Ali Al-Husry |
Executive Chairman: | Said Darwazah |
Independent Non-Executive Director: | Mary (Nina) Henderson, Victoria Hull , Cynthia Schwalm, Deneen Vojta, Douglas Hurt, John J. Castellani, Laura Balan Balan |
Executive Vice Chairman: | Mazen Darwazah |
Address: | 1 New Burlington Place, London,United Kingdom |
Phone: | +44 (0)20 7399 2760 |
Fax: | +44 (0)20 7399 2761 |
Website: | http://www.hikma.com |
Email: |
ISIN: | GB00B0LCW083 |
Sector: | Pharma and Biotech, Pharma and Biotech |
Main Indices: | FTSE 100, FTSE 350, FTSE All-Share |